AXSPA

Clinical trials for AXSPA explained in plain language.

Never miss a new study

Get alerted when new AXSPA trials appear

Sign up with your email to follow new studies for AXSPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial offers hope for Tough-to-Treat arthritis

Disease control Recruiting now

This study is testing an investigational drug called SPY002-072 to see if it can reduce disease activity in adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. It will compare the drug to a placebo in about 285 particip…

Matched conditions: AXSPA

Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

AXSPA

Get alerted when new AXSPA trials appear

New drug trial offers hope for Tough-to-Treat arthritis